The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Detalles Bibliográficos
Autores principales: Treon, Steven P., Castillo, Jorge J., Skarbnik, Alan P., Soumerai, Jacob D., Ghobrial, Irene M., Guerrera, Maria Luisa, Meid, Kirsten, Yang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243149/
https://www.ncbi.nlm.nih.gov/pubmed/32302379
http://dx.doi.org/10.1182/blood.2020006288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243149/
https://www.ncbi.nlm.nih.gov/pubmed/32302379
http://dx.doi.org/10.1182/blood.2020006288

Ejemplares similares